Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $398.01 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $125.00 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $102.30 | 1 | $0 (2024) |
| ABBVIE INC. | $31.13 | 2 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $23.32 | 1 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $22.80 | 1 | $0 (2023) |
| Mylan Specialty L.P. | $22.15 | 1 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $21.18 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $18.89 | 1 | $0 (2024) |
| VIVUS LLC | $17.75 | 1 | $0 (2023) |
| Electromed, Inc. | $13.49 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $183.47 | 5 | AstraZeneca Pharmaceuticals LP ($102.30) |
| 2023 | $200.22 | 5 | GlaxoSmithKline, LLC. ($125.00) |
| 2022 | $14.32 | 1 | ABBVIE INC. ($14.32) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2024 | Mylan Specialty L.P. | TOBI PODHALER (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Aminoglycosides | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $102.30 | General |
| 02/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/07/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/25/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2023 | Vertex Pharmaceuticals Incorporated | TRIKAFTA (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 10/04/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: HFCWO | ||||||
| 03/30/2023 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/02/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/05/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: ENDOCRINOLOGY | ||||||
About Dr. Grant Hamill, MD
Dr. Grant Hamill, MD is a Pediatric Critical Care Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2016. The National Provider Identifier (NPI) number assigned to this provider is 1760844898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grant Hamill, MD has received a total of $398.01 in payments from pharmaceutical and medical device companies, with $183.47 received in 2024. These payments were reported across 11 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($398.01).
Practice Information
- Specialty Pediatric Critical Care Medicine
- Other Specialties Pediatric Pulmonology
- Location Omaha, NE
- Active Since 03/28/2016
- Last Updated 12/01/2025
- Taxonomy Code 2080P0203X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760844898
Products in Payments
- NUCALA (Biological) $125.00
- ZENPEP (Drug) $44.50
- CREON (Drug) $31.13
- TRIKAFTA (Drug) $22.80
- TOBI PODHALER (Drug) $22.15
- DUPIXENT (Biological) $18.89
- PANCREAZE (Drug) $17.75
- SMARTVEST (Device) $13.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Critical Care Medicine Doctors in Omaha
Laura Ortmann, Md, MD
Pediatric Critical Care Medicine — Payments: $2,693
Rosann Nichols, Md, MD
Pediatric Critical Care Medicine — Payments: $749.24
Dr. Andrew Macfadyen, Md, MD
Pediatric Critical Care Medicine — Payments: $300.00
Dr. Mohan Mysore, Md, MD
Pediatric Critical Care Medicine — Payments: $252.61
Mr. Robert Chaplin, M.d, M.D
Pediatric Critical Care Medicine — Payments: $114.06
Rashmitha Dachepally, M.d, M.D
Pediatric Critical Care Medicine — Payments: $94.73